Related Experiment Video

Updated: Jan 31, 2026

Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies
08:33

Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies

Published on: April 12, 2022

4.0K

Clinical indicators for common paediatric conditions: Processes, provenance and products of the CareTrack Kids study

Louise K Wiles1,2,3, Tamara D Hooper1,2,3, Peter D Hibbert1,2,3,4,5,6

  • 1Australian Centre for Precision Health, School of Health Sciences, Cancer Research Institute, University of South Australia, Adelaide, South Australia, Australia.

Plos One
|January 10, 2019
PubMed

Insights

This study developed clinical indicators to assess appropriate paediatric care in Australia. The final set of 234 indicators helps measure healthcare quality for children across various settings.

Area of Science:

  • Healthcare Quality Improvement
  • Clinical Practice Guidelines
  • Paediatric Medicine

Background:

  • Assessing the appropriateness of paediatric care in Australia is crucial for evidence-based practice.
  • Clinical practice guidelines (CPGs) provide a foundation for defining appropriate care standards.

Purpose of the Study:

  • To develop a comprehensive set of clinical indicators for evaluating the appropriateness of care for 21 common paediatric medical conditions in Australia.
  • To establish a framework for measuring healthcare quality in paediatric settings.

Main Methods:

  • Systematic extraction of recommendations from 121 national and international guidelines.
  • Development and refinement of clinical indicators using a modified Delphi process and a collaborative online wiki involving 61 experts.
  • Focus on indicators for under-use of healthcare services, with feasibility as a key selection criterion.

Main Results:

  • A final set of 234 appropriateness indicators was developed, yielding 597 items for medical record audit.
  • The majority of indicators (92%) focused on capturing under-use of care.
  • Indicators were designed for diverse healthcare settings including emergency departments, hospitals, and general practices.

Conclusions:

  • A robust set of clinical indicators for paediatric care appropriateness was successfully developed in the Australian healthcare context.
  • The methodology, employing Delphi and wiki approaches, offers utility for creating consensus-based indicators.
  • The finalized indicators provide a practical tool for clinicians and organizations to audit and improve paediatric healthcare quality.
Abstract

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.7K
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

24.9K

Related Concept Videos

Indicators02:39

Indicators

Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
60.6K
Common Ion Effect03:24

Common Ion Effect

Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
46.6K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
217
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
341
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
558
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
342